Effect of oral penicillin on pneumococcal carriage in elderly men with chronic bronchitis

Area of Science:

• Infectious Diseases
• Pulmonology
• Pharmacology

Background:

• The pneumococcal carrier state is a significant concern, particularly in individuals with chronic respiratory conditions like chronic bronchitis.
• Streptococcus pneumoniae colonization can lead to complications and transmission, necessitating effective management strategies.

Purpose of the Study:

• To evaluate the efficacy of low-dose oral penicillin in eradicating the pneumococcal carrier state in men with chronic bronchitis.
• To assess the impact of phenoxymethyl penicillin on Streptococcus pneumoniae colonization over an extended treatment period.

Main Methods:

• A double-blind, randomized, placebo-controlled trial involving 32 men with chronic bronchitis.
• Participants received either 250-mg phenoxymethyl penicillin or placebo orally, twice daily, for one to three years.
• The primary outcome was the eradication of Streptococcus pneumoniae from the respiratory tract.

Main Results:

• Penicillin treatment led to the complete eradication of Streptococcus pneumoniae in all carrier patients.
• No discernible effect on the pneumococcal carrier state was observed in the placebo group (P = 0.0015).
• Prevention of pneumococcal colonization was maintained for the entire duration of penicillin treatment.

Conclusions:

• Daily low-dose oral penicillin is effective in eliminating pneumococci from the oropharynx of elderly patients with stable chronic bronchitis.
• Phenoxymethyl penicillin offers a viable therapeutic option for managing the pneumococcal carrier state in this population.
• The findings support the use of penicillin for long-term suppression of pneumococcal colonization in chronic bronchitis patients.